The proposed transaction would connect Oklahoma’s largest nonprofit health system with additional technology, investment, and care resources. Regulatory approval remains pending.
The investment includes $50 million for diabetes research and $100 million to educate health professionals, recruit researchers, and expand OU’s medical research infrastructure.
Blue Impact grants will support workforce opportunities, food access, housing, and health care across the state.
The Lawton hospital CEO will join OU Health in November, overseeing hospital and clinic operations and several major expansion projects.
The planned 160-acre development will include a hospital, outpatient care, research, medical training, and more than 5,500 employees at full buildout.
Acarix CEO Aamir Mahmood says Oklahoma can compete in medical technology by connecting research, talent, capital, and clinical partners.
Curtright succeeds founding CEO Richard Lofgren after serving nearly four years as chief operating officer of Oklahoma’s academic health system.
The gift will support OU Health’s expansion of comprehensive cancer care in northeastern Oklahoma.
The governor said the measure would rewrite Oklahoma’s prescription drug reimbursement formula and function as a “hidden tax” through higher premiums and health care costs.
A state-set fee on every prescription shifts costs to premiums and paychecks.
